Cnbx Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cnbx Pharmaceuticals Inc's ROI in the third quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Cnbx Pharmaceuticals Inc 's return on investment (ROI) in its third quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(May 31 2026) III. Quarter	(Feb 28 2026) II. Quarter	(Nov 30 2025) I. Quarter	(Aug 31 2025) IV. Quarter	(May 31 2025) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-3	-3	-3	-2	-3
Return On Investment (TTM)	-	-	-	-	-
CNBK's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	0	0	0	0	0

CNBK Company Profile >> Back to CNBK Roi Comparisons >> See Annual CNBK Return On Investment

Return On Investment CNBK's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Cnbx Pharmaceuticals Inc's III. Quarter Investments	$ -3 Millions	CNBK's Balance sheet
Cnbx Pharmaceuticals Inc's III. Quarter Income	$ 0 Millions	Quarterly CNBK's Income Statement
CNBK's Income by Division		See CNBK's Income by Division

CNBK Annual Return On Investment	(Aug 31 2025) 2025	(Aug 31 2024) 2024	(Aug 31 2023) 2023	(Aug 31 2022) 2022	(Aug 31 2021) 2021
Total Investments in Millions	-2	-2	-2	-2	2
Y / Y Investment Growth	-	-	-	-	2.34 %
Net Income in Millions	0	-1	-4	-4	-3
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-176.89 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNBK's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNBK's Competitors
Subscribers only: Roi for Cnbx Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CNBK's Customers

Other Ratios
CNBK's Roa	CNBK's Inventory Turnover Ratio	CNBK's Growth Rates	CNBK's Dividend Statistics
	CNBK's Profitability Ratios	CNBK's Asset Turnover Ratio	CNBK's Dividend Growth
CNBK's Roe	CNBK's Valuation Ratios	CNBK's Financial Strength Ratios	CNBK's Dividend Payout Ratio

Companies with similar Return On Investment at May 31 2026, within Healthcare Sector	ROI
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %
Alnylam Pharmaceuticals Inc	22.10 %
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %
Vertex Pharmaceuticals Inc	19.97 %
Agilent Technologies inc	19.84 %
Illumina Inc	19.61 %
Puma Biotechnology Inc	19.60 %
United Therapeutics Corporation	19.53 %

Date modified: 2026-07-01T13:22:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.